Username

Password

Preview

Sign-in free and Explore the Exciting World of BiomedExperts:

Over 1.500.000 Profiles
More than 1.800 Organizations worldwide
State of the Art Network Visualizations

Manage your own Profile
Locate Experts in your Country/Region
Locate Experts in your 1. and 2. Level Network
Connect to Experts Worldwide

NetworkView

Jon van Rood

This is a preview profile on BiomedExperts - the first literature-based scientific social network. It brings the right researchers together and allows them to collaborate online. Collexis and Dell provide the BiomedExperts network of +1.5 Million pre-calculated profiles free of charge to researchers worldwide.

Research Profile (preview)

Procedures

Chemicals & Drugs

Physiology

Anatomy

Living Beings

Tissue Donors

Disorders

Graft vs Host Disease

Concepts & Ideas

Sign-in to see full Profile

Sign-in to see all Coauthors

Publications

TOP 3
van Rood Jon J; Oudshoorn Machteld
When selecting an HLA mismatched stem cell donor consider donor immune status.
Hahn Theresa; McCarthy Philip L; Zhang Mei-Jie; Wang Dan; Arora Mukta; Frangoul Haydar; Gale Robert Peter; Hale Gregory A; Horan John; Isola Luis; Maziarz Richard T; van Rood Jon J; Gupta Vikas; Halter Joerg; Reddy Vijay; Tiberghien Pierre; Litzow Mark; Anasetti Claudio; Pavletic Stephen; Ringdén Olle
Risk factors for acute graft-versus-host disease after human leukocyte antigen-identical sibling transplants for adults with leukemia.
Griffioen Marieke; van der Meijden Edith D; Slager Elisabeth H; Honders M Willy; Rutten Caroline E; van Luxemburg-Heijs Simone A P; von dem Borne Peter A; van Rood Johannes J; Willemze Roel; Falkenburg J H Frederik
Identification of phosphatidylinositol 4-kinase type II beta as HLA class II-restricted target in graft versus leukemia reactivity.

Sign-in to see all Publications

Sign in free and see...

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the visualized research activity
of experts around the globe

Sign-in to see more

Geonetwork of Jon van Rood (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

Sign-in to see more

All Publications

2009: van Rood Jon J; Oudshoorn Machteld
When selecting an HLA mismatched stem cell donor consider donor immune status.
Current opinion in immunology 2009;21(5):538-43.
2008: Hahn Theresa; McCarthy Philip L; Zhang Mei-Jie; Wang Dan; Arora Mukta; Frangoul Haydar; Gale Robert Peter; Hale Gregory A; Horan John; Isola Luis; Maziarz Richard T; van Rood Jon J; Gupta Vikas; Halter Joerg; Reddy Vijay; Tiberghien Pierre; Litzow Mark; Anasetti Claudio; Pavletic Stephen; Ringdén Olle
Risk factors for acute graft-versus-host disease after human leukocyte antigen-identical sibling transplants for adults with leukemia.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2008;26(35):5728-34.
2008: Griffioen Marieke; van der Meijden Edith D; Slager Elisabeth H; Honders M Willy; Rutten Caroline E; van Luxemburg-Heijs Simone A P; von dem Borne Peter A; van Rood Johannes J; Willemze Roel; Falkenburg J H Frederik
Identification of phosphatidylinositol 4-kinase type II beta as HLA class II-restricted target in graft versus leukemia reactivity.
Proceedings of the National Academy of Sciences of the United States of America 2008;105(10):3837-42.
2008: van Rood J J; Oudshoorn M
Eleven million donors in Bone Marrow Donors Worldwide! Time for reassessment?
Bone marrow transplantation 2008;41(1):1-9.
2007: Feitsma Anouk L; Worthington Jane; van der Helm-van Mil Annette H M; Plant Darren; Thomson Wendy; Ursum Jennie; van Schaardenburg Dirkjan; van der Horst-Bruinsma Irene E; van Rood Jon J; Huizinga Tom W J; Toes René E M; de Vries René R P
Protective effect of noninherited maternal HLA-DR antigens on rheumatoid arthritis development.
Proceedings of the National Academy of Sciences of the United States of America 2007;104(50):19966-70.
2007: Heemskerk M B A; Cornelissen J J; Roelen D L; van Rood J J; Claas F H J; Doxiadis I I N; Oudshoorn M
Highly diverged MHC class I mismatches are acceptable for haematopoietic stem cell transplantation.
Bone marrow transplantation 2007;40(3):193-200.
2007: van der Burg Sjoerd H; Piersma Sytse J; de Jong Annemieke; van der Hulst Jeanette M; Kwappenberg Kitty M C; van den Hende Muriel; Welters Marij J P; Van Rood Jon J; Fleuren Gert Jan; Melief Cornelis J M; Kenter Gemma G; Offringa Rienk
Association of cervical cancer with the presence of CD4+ regulatory T cells specific for human papillomavirus antigens.
Proceedings of the National Academy of Sciences of the United States of America 2007;104(29):12087-92.
2007: Doxiadis Gaby G M; de Groot Nanine; Claas Frans H J; Doxiadis Ilias I N; van Rood Jon J; Bontrop Ronald E
A highly divergent microsatellite facilitating fast and accurate DRB haplotyping in humans and rhesus macaques.
Proceedings of the National Academy of Sciences of the United States of America 2007;104(21):8907-12.
2006: Keymeulen Bart; Gillard Pieter; Mathieu Chantal; Movahedi Babak; Maleux Geert; Delvaux Georges; Ysebaert Dirk; Roep Bart; Vandemeulebroucke Evy; Marichal Miriam; In 't Veld Peter; Bogdani Marika; Hendrieckx Christel; Gorus Frans; Ling Zhidong; van Rood Jon; Pipeleers Daniel
Correlation between beta cell mass and glycemic control in type 1 diabetic recipients of islet cell graft.
Proceedings of the National Academy of Sciences of the United States of America 2006;103(46):17444-9.
2006: Farag Sherif S; Bacigalupo Andrea; Eapen Mary; Hurley Carolyn; Dupont Bo; Caligiuri Michael A; Boudreau Christian; Nelson Gene; Oudshoorn Machteld; van Rood Jon; Velardi Andrea; Maiers Martin; Setterholm Michelle; Confer Dennis; Posch Phillip E; Anasetti Claudio; Kamani Naynesh; Miller Jeffrey S; Weisdorf Daniel; Davies Stella M;
The effect of KIR ligand incompatibility on the outcome of unrelated donor transplantation: a report from the center for international blood and marrow transplant research, the European blood and marrow transplant registry, and the Dutch registry.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2006;12(8):876-84.
2006: Hsu Katharine C; Gooley Ted; Malkki Mari; Pinto-Agnello Clara; Dupont Bo; Bignon Jean-Denis; Bornhäuser Martin; Christiansen Frank; Gratwohl Alois; Morishima Yasuo; Oudshoorn Machteld; Ringden Olle; van Rood Jon J; Petersdorf Effie;
KIR ligands and prediction of relapse after unrelated donor hematopoietic cell transplantation for hematologic malignancy.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2006;12(8):828-36.
2006: van den Boogaardt Daniëlle E M; van Rood Jon J; Roelen Dave L; Claas Frans H J
The influence of inherited and noninherited parental antigens on outcome after transplantation.
Transplant international : official journal of the European Society for Organ Transplantation 2006;19(5):360-71.
2006: Doxiadis Gaby G M; van der Wiel Marit K H; Brok Herbert P M; de Groot Natasja G; Otting Nel; 't Hart Bert A; van Rood Jon J; Bontrop Ronald E
Reactivation by exon shuffling of a conserved HLA-DR3-like pseudogene segment in a New World primate species.
Proceedings of the National Academy of Sciences of the United States of America 2006;103(15):5864-8.
2005: van den Boogaardt Daniëlle E M; van Miert Paula P M C; Koekkoek Karin M; de Vaal Yvonne J H; van Rood Jon J; Claas Frans H J; Roelen Dave L
No in vitro evidence for a decreased alloreactivity toward noninherited maternal HLA antigens in healthy individuals.
Human immunology 2005;66(12):1203-12.
2005: Seebach Jörg D; Stussi Georg; Passweg Jakob R; Loberiza Fausto R; Gajewski James L; Keating Armand; Goerner Martin; Rowlings Philip A; Tiberghien Pierre; Elfenbein Gerald J; Gale Robert Peter; van Rood Jon J; Reddy Vijay; Gluckman Eliane; Bolwell Brian J; Klumpp Thomas R; Horowitz Mary M; Ringdén Olle; Barrett A John;
ABO blood group barrier in allogeneic bone marrow transplantation revisited.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2005;11(12):1006-13.
2005: Heemskerk Martin B A; Roelen Dave L; Dankers Marlies K A; van Rood Jon J; Claas Frans H J; Doxiadis Ilias I N; Oudshoorn Machteld
Allogeneic MHC class I molecules with numerous sequence differences do not elicit a CTL response.
Human immunology 2005;66(9):969-76.
2005: Claas Frans H J; Dankers Marlies K; Oudshoorn Machteld; van Rood Jon J; Mulder Arend; Roelen Dave L; Duquesnoy Rene J; Doxiadis Ilias I N
Differential immunogenicity of HLA mismatches in clinical transplantation.
Transplant immunology 2005;14(3-4):187-91.
2005: van Rood J J; Roelen D L; Claas F H J
The effect of noninherited maternal antigens in allogeneic transplantation.
Seminars in hematology 2005;42(2):104-11.
2005: Heemskerk M B A; van Walraven S M; Cornelissen J J; Barge R M Y; Bredius R G M; Egeler R M; Tj Lie J L W; Révész T; Sintnicolaas K; Wulffraat N M; Donker A E; Hoogerbrugge P M; van Rood J J; Claas F H J; Oudshoorn M
How to improve the search for an unrelated haematopoietic stem cell donor. Faster is better than more!
Bone marrow transplantation 2005;35(7):645-52.
2005: Otting Nel; Heijmans Corrine M C; Noort Riet C; de Groot Natasja G; Doxiadis Gaby G M; van Rood Jon J; Watkins David I; Bontrop Ronald E
Unparalleled complexity of the MHC class I region in rhesus macaques.
Proceedings of the National Academy of Sciences of the United States of America 2005;102(5):1626-31.
2004: Laughlin Mary J; Eapen Mary; Rubinstein Pablo; Wagner John E; Zhang Mei-Jei; Champlin Richard E; Stevens Cladd; Barker Juliet N; Gale Robert P; Lazarus Hillard M; Marks David I; van Rood Jon J; Scaradavou Andromachi; Horowitz Mary M
Outcomes after transplantation of cord blood or bone marrow from unrelated donors in adults with leukemia.
The New England journal of medicine 2004;351(22):2265-75.
2004: Van Rood Jon J
Women, pregnancy and serendipity: a personal story about the discovery of HLA.
Journal of nephrology 2004;17(3):467-74.
2004: van Rood Jon J
Weighing optimal graft survival through HLA matching against the equitable distribution of kidney allografts.
The New England journal of medicine 2004;350(6):535-6.
2003: Vader Willemijn; Stepniak Dariusz; Kooy Yvonne; Mearin Luisa; Thompson Allan; van Rood Jon J; Spaenij Liesbeth; Koning Frits
The HLA-DQ2 gene dose effect in celiac disease is directly related to the magnitude and breadth of gluten-specific T cell responses.
Proceedings of the National Academy of Sciences of the United States of America 2003;100(21):12390-5.
2003: Gahrton G; van Rood J J; Oudshoorn M;
The World Marrow Donor Association (WMDA): its goals and activities.
Bone marrow transplantation 2003;32(2):121-4.
2003: Marijt W A Erik; Heemskerk Mirjam H M; Kloosterboer Freke M; Goulmy Els; Kester Michel G D; van der Hoorn Menno A W G; van Luxemburg-Heys Simone A P; Hoogeboom Manja; Mutis Tuna; Drijfhout Jan Wouter; van Rood Jon J; Willemze Roel; Falkenburg J H Frederik
Hematopoiesis-restricted minor histocompatibility antigens HA-1- or HA-2-specific T cells can induce complete remissions of relapsed leukemia.
Proceedings of the National Academy of Sciences of the United States of America 2003;100(5):2742-7.
2002: van Rood Jon J
On the clinical importance of privileged sites.
Human immunology 2002;63(10):799-804.
2002: de Groot Natasja G; Otting Nel; Doxiadis Gaby G M; Balla-Jhagjhoorsingh Sunita S; Heeney Jonathan L; van Rood Jon J; Gagneux Pascal; Bontrop Ronald E
Evidence for an ancient selective sweep in the MHC class I gene repertoire of chimpanzees.
Proceedings of the National Academy of Sciences of the United States of America 2002;99(18):11748-53.
2002: van Rood Jon J; Loberiza Fausto R; Zhang Mei-Jie; Oudshoorn Machteld; Claas Frans; Cairo Mitchell S; Champlin Richard E; Gale Robert Peter; Ringdén Olle; Hows Jill M; Horowitz Mary H
Effect of tolerance to noninherited maternal antigens on the occurrence of graft-versus-host disease after bone marrow transplantation from a parent or an HLA-haploidentical sibling.
Blood 2002;99(5):1572-7.
2001: Claas F H; Roelen D L; van Rood J J; Brand A
Modulation of the alloimmune response by blood transfusions.
Transfusion clinique et biologique : journal de la Société française de transfusion sanguine 2001;8(3):315-7.
2001: Heemskerk M H; de Paus R A; Lurvink E G; Koning F; Mulder A; Willemze R; van Rood J J; Falkenburg J H
Dual HLA class I and class II restricted recognition of alloreactive T lymphocytes mediated by a single T cell receptor complex.
Proceedings of the National Academy of Sciences of the United States of America 2001;98(12):6806-11.
2001: Hiemstra H S; Schloot N C; van Veelen P A; Willemen S J; Franken K L; van Rood J J; de Vries R R; Chaudhuri A; Behan P O; Drijfhout J W; Roep B O
Cytomegalovirus in autoimmunity: T cell crossreactivity to viral antigen and autoantigen glutamic acid decarboxylase.
Proceedings of the National Academy of Sciences of the United States of America 2001;98(7):3988-91.
2000: van Rood J J; Claas F
Noninherited maternal HLA antigens: a proposal to elucidate their role in the immune response.
Human immunology 2000;61(12):1390-4.
2000: van Rood J J; Claas F
Both self and non-inherited maternal HLA antigens influence the immune response.
Immunology today 2000;21(6):269-73.
2000: Niimi M; Roelen D L; Witzke O; van Rood J J; Claas F H; Wood K J
The importance of H2 haplotype sharing in the induction of specific unresponsiveness by pretransplant blood transfusions.
Transplantation 2000;69(3):411-7.
2000: Roelen D L; van Rood J J; Brand A; Claas F H
Immunomodulation by blood transfusions.
Vox sanguinis 2000;78 Suppl 2():273-5.
1999: Stobbe I; Duinkerken G; van Rood J J; Lernmark A; Keymeulen B; Pipeleers D; De Vries R R; Glass F H; Roep B O
Tolerance to kidney allograft transplanted into Type I diabetic patients persists after in vivo challenge with pancreatic islet allografts that express repeated mismatches.
Diabetologia 1999;42(11):1379-80.
1999: van Rood J J; van Leeuwen A
Soluble HLA antigens: how it all started.
Human immunology 1999;60(5):412-3.
1999: Claas F H; van Rood J J
Soluble HLA antigens and their peptides as immunoregulators and monitoring devices.
Human immunology 1999;60(5):398-400.
1999: Roep B O; Stobbe I; Duinkerken G; van Rood J J; Lernmark A; Keymeulen B; Pipeleers D; Claas F H; de Vries R R
Auto- and alloimmune reactivity to human islet allografts transplanted into type 1 diabetic patients.
Diabetes 1999;48(3):484-90.
1999: van der Horst-Bruinsma I E; Huizinga T W; Lagaay E M; Hazes J M; Breedveld F C; Schreuder G M; Tomson T A; Zwinderman A H; van Rood J J; de Vries R R
The influence of a partially HLA-matched blood transfusion on the disease activity of rheumatoid arthritis.
Rheumatology (Oxford, England) 1999;38(1):53-8.
1998: Jonker M; van de Hout Y; Neuhaus P; Ringers J; Kuhn E M; Bruijn J A; Noort R; Doxiadis G; Otting N; Bontrop R E; Claas F H; van Rood J J
Complete withdrawal of immunosuppression in kidney allograft recipients: a prospective study in rhesus monkeys.
Transplantation 1998;66(7):925-7.
1998: van Rood J J; Oudshoorn M
The quest for a bone marrow donor--optimal or maximal HLA matching?
The New England journal of medicine 1998;339(17):1238-9.
1998: Jonker M; van den Hout Y; Neuhaus P; Ringers J; Kuhn E M; Bruijn J A; Schuurman H J; Noort R; Bontrop R E; Claas F H; van Rood J J
Complete withdrawal of immunosuppression in kidney allograft recipients: a prospective study in rhesus monkeys.
Transplantation proceedings 1998;30(5):2451-3.
1998: Schipper R F; D'Amaro J; de Lange P; Schreuder G M; van Rood J J; Oudshoorn M
Validation of haplotype frequency estimation methods.
Human immunology 1998;59(8):518-23.
1998: van Rood J J; Oudshoorn M
An HLA matched donor! An HLA matched donor? What do you mean by: HLA matched donor?
Bone marrow transplantation 1998;22 Suppl 1():S83.
1998: van Rood J J; Schipper R F; Bakker J N; van der Zanden H G; Oudshoorn M
Bone Marrow Donors Worldwide and cord blood stem cell transplantation.
Bone marrow transplantation 1998;22 Suppl 1():S19-21.
1997: Oudshoorn M; Cornelissen J J; Fibbe W E; de Graeff-Meeder E R; Lie J L; Schreuder G M; Sintnicolaas K; Willemze R; Vossen J M; van Rood J J
Problems and possible solutions in finding an unrelated bone marrow donor. Results of consecutive searches for 240 Dutch patients.
Bone marrow transplantation 1997;20(12):1011-7.
1997: Szydlo R; Goldman J M; Klein J P; Gale R P; Ash R C; Bach F H; Bradley B A; Casper J T; Flomenberg N; Gajewski J L; Gluckman E; Henslee-Downey P J; Hows J M; Jacobsen N; Kolb H J; Lowenberg B; Masaoka T; Rowlings P A; Sondel P M; van Bekkum D W; van Rood J J; Vowels M R; Zhang M J; Horowitz M M
Results of allogeneic bone marrow transplants for leukemia using donors other than HLA-identical siblings.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1997;15(5):1767-77.
1997: van Rood J J
1996 Medawar Prize Lecture--looking back and forward.
Transplantation proceedings 1997;29(1-2):39-42.
1997: Schipper R F; D'Amaro J; Bakker J T; Bakker J; van Rood J J; Oudshoorn M
HLA gene haplotype frequencies in bone marrow donors worldwide registries.
Human immunology 1997;52(1):54-71.
1996: Bouma G J; Hollander D A; van der Meer-Prins E M; van Bree S P; van Rood J J; van der Woude F J; Claas F H
In vitro sensitivity to prednisolone may predict kidney rejection after steroid withdrawal.
Transplantation 1996;62(10):1422-9.
1996: Bouma G J; van Caubergh P; van Bree S P; Castelli-Visser R M; Witvliet M D; van der Meer-Prins E M; van Rood J J; Claas F H
Pregnancy can induce priming of cytotoxic T lymphocytes specific for paternal HLA antigens that is associated with antibody formation.
Transplantation 1996;62(5):672-8.
1996: Doxiadis I I; Smits J M; Schreuder G M; Persijn G G; van Houwelingen H C; van Rood J J; Claas F H
Association between specific HLA combinations and probability of kidney allograft loss: the taboo concept.
Lancet 1996;348(9031):850-3.
1996: Schipper R F; Oudshoorn M; D'Amaro J; van der Zanden H G; de Lange P; Bakker J T; Bakker J; van Rood J J
Validation of large data sets, an essential prerequisite for data analysis: an analytical survey of the Bone Marrow Donors Worldwide.
Tissue antigens 1996;47(3):169-78.
1996: Zantvoort F A; D'Amaro J; Persijn G G; Cohen B; Schreuder G M; Van Rood J J; Thorogood J
The impact of HLA-A matching on long-term survival of renal allografts.
Transplantation 1996;61(5):841-4.
1996: Doxiadis I I; Smits J M; Stobbe I; Schreuder G M; Persijn G G; van Houwelingen H; van Rood J J; Claas F H
Taboo HLA mismatches in cadaveric renal transplantation: definition, analysis, and possible implications.
Transplantation proceedings 1996;28(1):224.
1996: Goulmy E; Schipper R; Pool J; Blokland E; Falkenburg J H; Vossen J; Gratwohl A; Vogelsang G B; van Houwelingen H C; van Rood J J
Mismatches of minor histocompatibility antigens between HLA-identical donors and recipients and the development of graft-versus-host disease after bone marrow transplantation.
The New England journal of medicine 1996;334(5):281-5.
1996: Bouma G J; Schanz U; Oudshoorn M; van der Meer-Prins P M; Roelen D L; van Rood J J; Claas F H
A cell-saving non-radioactive limiting dilution analysis-assay for the combined determination of helper and cytotoxic T lymphocyte precursor frequencies.
Bone marrow transplantation 1996;17(1):19-23.
1995: Termijtelen A; D'Amaro J; van Rood J J; Schreuder G M
Linkage disequilibrium in HLA cannot be explained by selective recombination.
Tissue antigens 1995;46(5):387-90.
1995: Roelen D L; van Bree F P; van Beelen E; van Rood J J; Claas F H
No evidence of an influence of the noninherited maternal HLA antigens on the alloreactive T cell repertoire in healthy individuals.
Transplantation 1995;59(12):1728-33.
1995: Bouma G J; van der Meer-Prins E M; van der Woude F J; van Rood J J; Claas F H
Relevance of pretransplant donor-specific T cell allorepertoire for human kidney graft survival.
Transplantation 1995;59(7):969-76.
1995: Roelen D L; van Beelen E; van Bree S P; van Rood J J; Völker-Dieben H J; Claas F H
The presence of activated donor HLA class I-reactive T lymphocytes is associated with rejection of corneal grafts.
Transplantation 1995;59(7):1039-42.
1994: Oudshoorn M; van Leeuwen A; vd Zanden H G; van Rood J J
Bone Marrow Donors Worldwide: a successful exercise in international cooperation.
Bone marrow transplantation 1994;14(1):3-8.
1994: Roelen D L; van Bree J; Witvliet M D; Habraken I; van Beelen E; van't Sant P H; de Waal L P; van Rood J J; Claas F H
IgG antibodies against an HLA antigen are associated with activated cytotoxic T cells against this antigen, IgM are not.
Transplantation 1994;57(9):1388-92.
1994: Schanz U; Roelen D L; Bruning J W; Kardol M J; van Rood J J; Claas F H
The relative radioresistance of interleukin-2 production by human peripheral blood lymphocytes: consequences for the development of a new limiting dilution assay for the enumeration of helper T lymphocyte precursor frequencies.
Journal of immunological methods 1994;169(2):221-30.
1994: van der Mast B J; Hornstra N; Ruigrok M B; Claas F H; van Rood J J; Lagaaij E L
Transfusion-associated graft-versus-host disease in immunocompetent patients: a self-protective mechanism.
Lancet 1994;343(8900):753-7.
1994: Roelen D L; van Bree S P; van Beelen E; Schanz U; van Rood J J; Claas F H
Cytotoxic T lymphocytes against HLA-B antigens are less naive than cytotoxic T lymphocytes against HLA-A antigens.
Transplantation 1994;57(3):446-50.
1993: Thorogood J; Doxiadis I I; Schreuder G M; Persijn G G; van Rood J J
Survival of serologically HLA typed and matched cadaveric kidney transplants and patients: influence of serologic retyping of donors.
Transplantation proceedings 1993;25(6):3051-2.
1993: Thorogood J; Schreuder G M; Persijn G G; van Rood J J
Organ sharing based on HLA matching saves dialysis years and patient lives.
Transplantation proceedings 1993;25(6):3049-50.
1993: Roelen D L; van Bree F P; Schanz U; van Rood J J; Claas F H
Differential inhibition of primed alloreactive CTLs in vitro by clinically used concentrations of cyclosporine and FK506.
Transplantation 1993;56(1):190-5.
1993: de Bueger M; Bakker A; Bontkes H; van Rood J J; Goulmy E
High frequencies of cytotoxic T cell precursors against minor histocompatibility antigens after HLA-identical BMT: absence of correlation with GVHD.
Bone marrow transplantation 1993;11(5):363-8.
1993: Claas F H; de Koster H S; Lagaaij E L; van Rood J J
A molecular mechanism of T cell downregulation by blood transfusion.
Experimental nephrology 1993;1(2):134-8.
1993: Thorogood J; van Houwelingen J C; Persijn G G; van Rood J J
Match prognostic index for predicting waiting time to renal transplantation.
Transplantation proceedings 1993;25(1 Pt 2):1039-40.
1993: van Rood J J
The impact of the HLA-system in clinical medicine.
Schweizerische medizinische Wochenschrift 1993;123(3):85-92.
1993: ten Wolde S; Breedveld F C; de Vries R R; D'Amaro J; Rubenstein P; Schreuder G M; Claas F H; van Rood J J
Influence of non-inherited maternal HLA antigens on occurrence of rheumatoid arthritis.
Lancet 1993;341(8839):200-2.
1993: Schreuder G M; Pool J; Blokland E; van Els C; Bakker A; van Rood J J; Goulmy E
A genetic analysis of human minor histocompatibility antigens demonstrates Mendelian segregation independent of HLA.
Immunogenetics 1993;38(2):98-105.
1993: van Rood J J
HLA and I.
Annual review of immunology 1993;11():1-28.
1993: Oudshoorn M; van Leeuwen A; vd Zanden H G; van Rood J J
Bone marrow donors worldwide.
Bone marrow transplantation 1993;11 Suppl 1():35-7.
1993: van Leeuwen A; Oudshoorn M; Schreuder I M; Giphart M J; Claas F H; van Rood J J
Laboratory procedures used to select an unrelated HLA matched bone marrow donor.
Bone marrow transplantation 1993;11 Suppl 1():13-6.
1993: van Rood J J; Lagaaij E L; Doxiadis I; Roelen D; Persijn G; Claas F
Permissible mismatches, acceptable mismatches, and tolerance: new trends in decision making.
Clinical transplants 1993;():285-92.
1992: Thorogood J; Schreuder G M; Persijn G G; van Rood J J
Quality of serological donor HLA typing: analysis of graft survival by HLA in renal transplantation recipients treated with cyclosporine.
Transplantation proceedings 1992;24(6):2485-7.
1992: Bouma G J; van der Meer-Prins P M; van Bree F P; van Rood J J; Claas F H
Determination of cytotoxic T-lymphocyte precursor frequencies using europium labeling as a nonradioactive alternative to labeling with chromium-51.
Human immunology 1992;35(2):85-92.
1992: de Bueger M; Bakker A; Van Rood J J; Van der Woude F; Goulmy E
Tissue distribution of human minor histocompatibility antigens. Ubiquitous versus restricted tissue distribution indicates heterogeneity among human cytotoxic T lymphocyte-defined non-MHC antigens.
Journal of immunology (Baltimore, Md. : 1950) 1992;149(5):1788-94.
1992: Thorogood J; van Houwelingen J C; van Rood J J; Zantvoort F A; Schreuder G M; Persijn G G
Factors contributing to long-term kidney graft survival in Eurotransplant.
Transplantation 1992;54(1):152-8.
1992: de Koster H S; van Rood J J; Termijtelen A
HLA-DR peptide-induced alloreactive T cell lines reveal an HLA-DR sequence that can be both "dominant" and "cryptic": evidence for allele-specific processing.
European journal of immunology 1992;22(6):1531-9.
1992: Roelen D; Datema G; van Bree S; Zhang L; van Rood J; Claas F
Evidence that antibody formation against a certain HLA alloantigen is associated not with a quantitative but with a qualitative change in the cytotoxic T cells recognizing the same antigen.
Transplantation 1992;53(4):899-903.
1992: Thorogood J; van Houwelingen J C; van Rood J J; Zantvoort F A; Schreuder G M; Persijn G G
Factors affecting the long-term outcome following non-living kidney transplantation.
Transplant international : official journal of the European Society for Organ Transplantation 1992;5 Suppl 1():S138-9.
1992: van Els C A; D'Amaro J; Pool J; Blokland E; Bakker A; van Elsen P J; van Rood J J; Goulmy E
Immunogenetics of human minor histocompatibility antigens: their polymorphism and immunodominance.
Immunogenetics 1992;35(3):161-5.
1991: Goulmy E; Bittner K; Blokland E; Pool J; Persijn G; van Rood J J; Lange H
Renal transplant patients with steroid withdrawal evaluated longitudinally for their donor--specific cytotoxic T cell reactivity.
Transplantation 1991;52(6):1083-5.
1991: Zhang L; van Bree S; van Rood J J; Claas F H
Influence of breast feeding on the cytotoxic T cell allorepertoire in man.
Transplantation 1991;52(5):914-6.
1991: Thorogood J; Houwelingen J C; Persijn G G; Zantvoort F A; Schreuder G M; van Rood J J
Prognostic indices to predict survival of first and second renal allografts.
Transplantation 1991;52(5):831-6.
1991: Lagaaij E L; Ruigrok M B; van Rood J J; Hendriks G F; van der Woude F; Weimar W; van Houwelingen H C; Goulmy E
Blood transfusion induced changes in cell-mediated lympholysis: to immunize or not to immunize.
Journal of immunology (Baltimore, Md. : 1950) 1991;147(10):3348-52.
1991: van Rood Y; Goulmy E; Blokland E; Pool J; van Rood J; van Houwelingen H
Month-related variability in immunological test results; implications for immunological follow-up studies.
Clinical and experimental immunology 1991;86(2):349-54.
1991: De Bueger M; Bakker A; Van Rood J J; Goulmy E
Minor histocompatibility antigens, defined by graft-vs.-host disease-derived cytotoxic T lymphocytes, show variable expression on human skin cells.
European journal of immunology 1991;21(11):2839-44.
1991: Schreuder G M; van den Berg-Loonen P M; Verduyn W; Geraets D P; Parlevliet J; van Rood J J; Giphart M J
Increasing complexity of HLA-DR2 as detected by serology and oligonucleotide typing.
Human immunology 1991;32(2):141-9.
1991: Termijtelen A; Erlich H A; Braun L A; Verduyn W; Drabbels J J; Schroeijers W E; van Rood J J; de Koster H S; Giphart M J
Oligonucleotide typing is a perfect tool to identify antigens stimulatory in the mixed lymphocyte culture.
Human immunology 1991;31(4):241-5.
1991: Zhang L; van Bree S; Gijbels Y; van Veen A; van Rood J J; Class F H
Comparison of the humoral and cytotoxic T-lymphocyte response to individual HLA class I alloantigens in highly immunized patients.
Human immunology 1991;30(3):156-61.
1991: Thorogood J; van Houwelingen J C; Persijn G G; Zantvoort F A; Schreuder G M; van Rood J J
Prognostic indices for first and second transplants can predict kidney graft survival.
Transplantation proceedings 1991;23(1 Pt 2):1330-1.
1991: Goulmy E; Voogt P; van Els C; de Bueger M; van Rood J
The role of minor histocompatibility antigens in GVHD and rejection: a mini-review.
Bone marrow transplantation 1991;7 Suppl 1():49-51.
1991: van Rood J J; van Leeuwen A; Oudshoorn M
Bone marrow donors worldwide (BMDW).
Bone marrow transplantation 1991;7 Suppl 2():128.
1991: Claas F H; Lagaay E L; van Rood J J
Immunological consequences of blood transfusions.
Schweizerische medizinische Wochenschrift. Supplementum 1991;43():70-2.
1990: Thorogood J; van Houwelingen J C; Persijn G G; van Rood J J
The contribution of failure time of first kidney graft to predicting failure of regrafts.
Transplantation proceedings 1990;22(4):1915-6.
1990: Vandekerckhove B A; Datema G; Koning F; Goulmy E; Persijn G G; van Rood J J; Claas F H; de Vries J E
Analysis of the donor-specific cytotoxic T-cell repertoire in a patient with a long-term surviving kidney allograft.
Transplantation proceedings 1990;22(4):1871-2.
1990: van Els C A; Bakker A; Zwinderman A H; Zwaan F E; van Rood J J; Goulmy E
Effector mechanisms in graft-versus-host disease in response to minor histocompatibility antigens. I. Absence of correlation with cytotoxic effector cells.
Transplantation 1990;50(1):62-6.
1990: Thorogood J; Persijn G G; Schreuder G M; D'Amaro J; Zantvoort F A; van Houwelingen J C; van Rood J J
The effect of HLA matching on kidney graft survival in separate posttransplantation intervals.
Transplantation 1990;50(1):146-50.
1990: van Els C A; Bakker A; Zwinderman A H; Zwaan F E; van Rood J J; Goulmy E
Effector mechanisms in graft-versus-host disease in response to minor histocompatibility antigens. II. Evidence of a possible involvement of proliferative T cells.
Transplantation 1990;50(1):67-71.
1990: van Els C A; Zantvoort E; Jacobs N; Bakker A; van Rood J J; Goulmy E
Graft-versus-host disease associated T helper cell responses specific for minor histocompatibility antigens are mainly restricted by HLA-DR molecules.
Bone marrow transplantation 1990;5(6):365-72.
1990: van Rood J J; Claas F H
The influence of allogeneic cells on the human T and B cell repertoire.
Science (New York, N.Y.) 1990;248(4961):1388-93.
1990: van Els C A; Bakker A; van Rood J J; Goulmy E
Induction of minor histocompatibility antigen-specific T-helper but not T-cytotoxic response is dependent on the source of antigen-presenting cell.
Human immunology 1990;28(1):39-50.
1990: Vijverberg K; Schreuder G M; Kenter M J; Naipal A M; van Rood J J; Giphart M J
Applicability of HLA-DQB oligonucleotide typing for the TA10 and 2B3 specificities in routine HLA typing.
Tissue antigens 1990;35(4):165-71.
1990: Vandekerckhove B A; Datema G; Koning F; Goulmy E; Persijn G G; Van Rood J J; Claas F H; De Vries J E
Analysis of the donor-specific cytotoxic T lymphocyte repertoire in a patient with a long term surviving allograft. Frequency, specificity, and phenotype of donor-reactive T cell receptor (TCR)-alpha beta+ and TCR-gamma delta+ clones.
Journal of immunology (Baltimore, Md. : 1950) 1990;144(4):1288-94.
1989: Goulmy E; Stijnen T; Groenewoud A F; Persijn G G; Blokland E; Pool J; Paul L C; van Rood J J
Renal transplant patients monitored by the cell-mediated lympholysis assay. Evaluation of its clinical value.
Transplantation 1989;48(4):559-63.
1989: van Rood J J
The impact of the HLA system in clinical hematology.
Blut 1989;59(3):214-20.
1989: Lagaaij E L; Hennemann I P; Ruigrok M; de Haan M W; Persijn G G; Termijtelen A; Hendricks G F; Weimar W; Claas F H; van Rood J J
Effect of one-HLA-DR-antigen-matched and completely HLA-DR-mismatched blood transfusions on survival of heart and kidney allografts.
The New England journal of medicine 1989;321(11):701-5.
1989: Thorogood J; van Houwelingen J C; van Rood J J; Persijn G G
The effect of HLA-matching, cyclosporin-A, and transplant year on annual kidney graft survival.
Transplantation proceedings 1989;21(4):3723-4.
1989: Thorogood J; van Houwelingen J C; van Rood J J; Persijn G G
The impact of center variation on the HLA-DR matching effect in kidney graft survival.
Transplantation 1989;48(2):231-8.
1989: Zhang L; Li S G; Vandekerckhove B; Termijtelen A; Van Rood J J; Claas F H
Analysis of cytotoxic T cell precursor frequencies directed against individual HLA-A and -B alloantigens.
Journal of immunological methods 1989;121(1):39-45.
1989: Claas F H; van Leeuwen A; van Rood J J
Hyperimmunized patients do not need to wait for an HLA identical donor.
Tissue antigens 1989;34(1):23-9.
1989: van Rood J J; Zhang L; van Leeuwen A; Claas F H
Neonatal tolerance revisited.
Immunology letters 1989;21(1):51-4.
1989: Zantvoort F A; Persijn G G; van Rood J J
Renal allograft and patient survival in combined pancreas/kidney transplantation.
Transplantation proceedings 1989;21(1 Pt 3):2831-2.
1989: Claas F H; Gijbels Y; von Veen A; de Waal L P; D'Amaro J; Persijn G G; van Rood J J
Selection of cross-match negative HLA-A and/or -B mismatched donors for highly sensitized patients.
Transplantation proceedings 1989;21(1 Pt 1):665-6.
1989: Persijn G G; D'Amaro J; de Lange P; Schreuder G M; van Rood J J
Modulation of the HLA-A, -B, -DR matching effect by cyclosporin therapy.
Transplantation proceedings 1989;21(1 Pt 1):656-8.
1989: van Els C; Bakker A; Zwaan F; van Rood J J; Goulmy E
Incidence of anti-host cytotoxic and proliferative T cell responses after HLA-identical bone marrow transplantation (BMT).
Transplantation proceedings 1989;21(1 Pt 3):2987-8.
1989: Kenter M J; Anholts J D; Schreuder G M; van Eggermond M C; Ghyselen G M; van Rood J J; Giphart M J
Unambiguous typing for HLA-DQ TA10 and 2B3 specificities using specific oligonucleotide probes.
Human immunology 1989;24(1):65-73.
1989: Claas F H; van Rood J J
Transplantation in hyperimmunized patients.
Advances in nephrology from the Necker Hospital 1989;18():317-23.
1989: Claas F H; de Waal L P; Beelen J; Reekers P; Berg-Loonen P V; de Gast E; D'Amaro J; Persijn G G; Zantvoort F; van Rood J J
Transplantation of highly sensitized patients on the basis of acceptable HLA-A and B mismatches.
Clinical transplants 1989;():185-90.
1988: Roep B O; Bontrop R E; Peña A S; van Eggermond M C; van Rood J J; Giphart M J
An HLA-DQ alpha allele identified at DNA and protein level is strongly associated with celiac disease.
Human immunology 1988;23(4):271-9.
1988: Thorogood J; van Houwelingen J C; van Rood J J; Persijn G G
Time trend in annual kidney graft survival.
Transplantation 1988;46(5):686-90.
1988: Claas F H; Gijbels Y; van der Velden-de Munck J J; de Waal L P; D'Amaro J; Hendriks G F; Persijn G G; van Rood J J
A special strategy to increase the chance of finding cross-match negative kidneys for highly sensitized patients.
Transplantation proceedings 1988;20(5):947-8.
1988: van Rood J J; Zwaan F E; Willemze R
The unrelated bone marrow donor.
Bone marrow transplantation 1988;3(5):371-7.
1988: Claas F H; Gijbels Y; van der Velden-de Munck J; van Rood J J
Induction of B cell unresponsiveness to noninherited maternal HLA antigens during fetal life.
Science (New York, N.Y.) 1988;241(4874):1815-7.
1988: Schroeijers W E; de Koster H S; van Rood J J; Termijtelen A
HLA-DR beta III and HLA-DP induce comparable proliferation in primary mixed lymphocyte culture.
Tissue antigens 1988;32(3):145-9.
1988: Jager M J; Claas F H; Schot J D; Gratama J W; de Lange G; van Rood J J
Genetics of two human monocyte antigens.
Human immunology 1988;22(3):163-70.
1988: Claas F H; van Rood J J
The hyperimmunized patient: from sensitization toward transplantation.
Transplant international : official journal of the European Society for Organ Transplantation 1988;1(2):53-7.
1988: Termijtelen A; Gorski J; Robbins F M; Tanigaki N; Tosi R; Tilanus M G; Schroeijers W E; van Rood J J
Correlations between polymorphisms at the DNA and at the protein level of DRw52 haplotypes, revealed with a variety of techniques.
Human immunology 1988;22(3):171-8.
1988: Bontrop R E; Tilanus M G; Mikulski M M; Elferink D G; Termijtelen A; de Vries R R; van Rood J J; Giphart M J
Polymorphism and complexity of HLA-DR: evidence for intra-HLA-DR region crossing-over events.
Immunogenetics 1988;27(1):40-5.
1988: Persijn G G; D'Amaro J; De Lange P; Schreuder G M; Thorogood J; Zantvoort F; Van Rood J J
The effect of mismatching and sharing of HLA-A, -B, and -DR antigens on kidney graft survival in Eurotransplant 1982 to 1988.
Clinical transplants 1988;():237-48.
1987: van Rood J J
Matched or mismatched? That is the question.
Bone marrow transplantation 1987;2(4):347-9.
1987: Lagaaij E L; Persijn G G; Termijtelen A; Hendricks G F; de Lange P; van Rood J J
Evidence that the difference in kidney graft survival in DRw6+ and DRw6- recipients may be explained by a blood transfusion policy that is disadvantageous for DRw6+ recipients.
Transplantation 1987;44(6):788-91.
1987: Nagesser S K; Bosch M L; van Rood J J; Termijtelen A
Matching for supertypic DR epitopes does not reduce mixed lymphocyte culture reactivity.
Scandinavian journal of immunology 1987;26(4):455-8.
1987: Hendriks G F; de Lange P; Persijn G G; van Rood J J
Cyclosporine A, hyperimmunized patients, and renal retransplantation.
Transplantation proceedings 1987;19(1 Pt 1):733-4.
1987: Hendriks G F; de Lange P; Schreuder G M; D'Amaro J; Persijn G G; van Rood J J
The impact of cyclosporine A on the DRw6 effect in renal transplantation.
Transplantation proceedings 1987;19(1 Pt 1):650-1.
1987: van Rood J J; Goulmy E; van Leeuwen A
The immunogenetics of chronic graft versus host disease and its relevance for the graft versus leukemia effect.
Progress in clinical and biological research 1987;244():433-8.
1986: Persijn G G; de Lange P; D'Amaro J; Cohen B; Liebelt P; Hendriks G F; van Rood J J
Eurotransplant. Part II. The cyclosporine era 1981-1985.
Clinical transplants 1986;():99-107.
1985: Hendriks G F; de Lange P; D'Amaro J; Schreuder G M; Claas F H; Persijn G G; van Rood J J
Eurotransplant experience with highly immunized patients.
Scandinavian journal of urology and nephrology. Supplementum 1985;92():81-6.
1984: Naipal A M; D'Amaro J; Bruning J W; van Leeuwen A; van Rood J J
Automated reading of Propidium Iodide lymphocytotoxicity tests for HLA-DR, MB, MT typing.
Tissue antigens 1984;24(5):302-6.

Sign-in to see more

Sign-in free and Explore the Exciting World of BiomedExperts:

NetworkView

Jon van Rood

Research Profile (preview)

Procedures

Chemicals & Drugs

Physiology

Anatomy

Living Beings

Disorders

Concepts & Ideas

Network (preview)

Publications

Sign in free and see...

Visualized networks:

GeoTargeted Searches:

Research Profiles:

Geonetwork of Jon van Rood (preview)

All Publications